Target intelligence / Profile preview

Solute carrier family 19 member 2 (SLC19A2), also known as Thiamine transporter 1 (SLC19A2; also referred to as TPHT1, ThTr-1, or TC1)

Target
SLC19A2; also referred to as TPHT1, ThTr-1, or TC1
Molecular classification
Transporter (primary classification), Major Facilitator Superfamily (MFS) protein, Twelve-pass transmembrane protein, Solute carrier protein, Vitamin transporter
01

Overview

Vitamin B1 transport is mediated primarily by solute carrier family 19 member 2 (SLC19A2), a major facilitator superfamily transporter protein that catalyzes the high-affinity, energy-dependent uptake of thiamine (vitamin B1) across cellular membranes. This transporter is essential for cellular accumulation of thiamine, a vital cofactor for multiple metabolic enzymes involved in energy production and nucleotide synthesis. SLC19A2 cycles through outward-open and inward-open conformations to recognize and transport thiamine and its phosphorylated derivatives (TDP and TMP) with a Km in the low micromolar range (2–7 μM). Mutations in SLC19A2 cause thiamine-responsive megaloblastic anemia (TRMA), an autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness, highlighting the critical importance of this transporter for human health. The transporter functions as a therapeutic target for conditions involving thiamine deficiency and represents an important nutrient uptake mechanism that can be affected by certain drug interactions, making it clinically relevant for vitamin supplementation strategies and genetic disease management.

Other names
Thiamine transporter 1 (TPHT1)Thiamine carrier 1Solute carrier family 19 member 2ThTr-1ThTr1TC1
02

Mechanism of action

At low thiamine concentrations, SLC19A2 mediates carrier-mediated, energy-dependent uptake. Exhibits Km values of 2–7 μM, indicating strong substrate recognition. The transporter cycles between outward-open and inward-open conformations to facilitate substrate translocation across the membrane. Recognizes thiamine and phosphorylated thiamine derivatives with specificity through coordinated binding interactions in the substrate pocket.

03

Biological functions

Cellular accumulation of thiamine (vitamin B1) — SLC19A2 mediates high-affinity uptake of thiamine across cell membranesNutrient transport — Facilitates the movement of vitamin B1 from the extracellular space into cellsMetabolic cofactor supply — Enables cellular access to thiamine, which is essential for energy metabolismCellular homeostasis — Maintains appropriate intracellular vitamin B1 levels for enzymatic function
04

Disease associations

Thiamine-responsive megaloblastic anemia (TRMA) — Mutations in SLC19A2 cause this autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafnessThiamine deficiency disorders — Impaired SLC19A2 functionality leads to systemic thiamine deficiencyNeurological disease (indirect) — Thiamine deficiency affects nervous system function due to reduced cofactor availabilityMetabolic disease — Associated with diabetes mellitus phenotypes in genetic disorders
05

Safety considerations

Loss-of-function mutations — SLC19A2 mutations cause severe, life-threatening symptoms including anemia and diabetesThiamine deficiency — Impaired transporter function results in systemic vitamin B1 deficiency, affecting multiple organ systemsDrug interactions — Certain compounds (e.g., patiromer) may inhibit transporter function, reducing thiamine bioavailabilityLimited compensatory mechanisms — While SLC19A3 exists as a related transporter, loss of SLC19A2 function cannot be fully compensated by alternative pathways in certain tissues
06

Interacting drugs

Thiamine (vitamin B1) — Substrate/ligand with high-affinity binding (Km = 2–7 μM)

2 more in the full profile.

07

Biomarkers

SLC19A2 genetic mutations — Variants in SLC19A2 are diagnostic biomarkers for thiamine-responsive megaloblastic anemiaThiamine plasma/cellular levels — Used to assess transporter function and thiamine statusTransporter expression levels — May indicate cellular capacity for thiamine uptake

Beyond the preview

Go deeper on Solute carrier family 19 member 2 (SLC19A2), also known as Thiamine transporter 1 (SLC19A2; also referred to as TPHT1, ThTr-1, or TC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 19 member 2 (SLC19A2), also known as Thiamine transporter 1 (SLC19A2; also referred to as TPHT1, ThTr-1, or TC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call